8. Brown, E.A., Talbot, G.H., Provencher, M. and Cassileth, P.A.: Anaerobic bacteremia in patients with acute 
leukemia. Infect. Control Hosp. Epidemiol. 10:65-69, 1989. 
9. Kahn, S.B., Ebrahim, K„ Cassileth, P.A., Bennett, J.M., Wolter, J.M. and O’Connell, M.J.: Attenuated high-dose 
cytosine arabinoside in the treatment of the elderly patient with acute non-lymphocytic leukemia. An ECOG pilot 
study. Amer. J. Clin. Oncol. 12:201-204, 1989. 
10. Stadtmauer, E., Cassileth, P.A. and Gale, R.P.: Etoposide in leukemia, lymphoma and bone marrow transplantation. 
Leukemia Res. 13:639-650, 1989. 
11. Cassileth, P.A., Andersen, J.W., Hoagland, H.C., Mazza, J.J., Bennett, J.M., Tormey, D.C. and O’Connell, M.J.: 
High-dose cytarabine in adult acute lymphocytic leukemia. In Acute Lymphoblastic Leukemia, Alan R. Liss, New 
York, 1989, p 197-203. 
12. Cassileth, P.A., Harrington, D.P., Hines, J.D., Oken, M.M., Mazza, J.J., McGlave, P., Bennett, J.M., Lynch, E. and 
O’Connell, M.J.: Comparison of post remission therapies in adult acute myeloid leukemia: preliminary analysis of 
an ECOG study. Haematol, and Blood Transfus. 33:267-270, 1990. 
13. Cheson, B.D., Cassileth, P.A., Head, D.R., Schiffer, C.A., Bennett, J.M., Bloomfield, C.D., Brunning, R., Gale, R.P., 
Grever, M.R., Keating, M.J., Sawitshy, A., Stass, S., Weinstein, H. and Woods, W.G.: Report of National Cancer 
Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J. Clin. Oncol. 
8:813-819, 1990. 
14. Cassileth, P.A.: Intensive therapy in elderly patients with acute myeloid leukemia. J. Clin. Oncol. 8:937,1990. 
15. Rowe, J.M., Mazza, J.J., Hines, J.D., Cassileth, P.A., Oken, M.M., Bennett, J.M., Andersen, J.: Mitoxantrone and 
etoposide in patients with relapsed and refractory acute non lymphocytic leukemia. Haematol, and Blood Transfus. 
33:267-70, 1990. 
16. Rowe, M.R., Cassileth, P.A., Oken, M.M., Andersen, J.W., Bennett, J.M. and Wiemik, P.H.: Clinical trials in adults 
with acute myelogenous leukemia: the ECOG experience. In Acute Myelogenous Leukemia: Progress and 
Controversies, Wiley-Liss, 1990, p 293-302. 
17. Hochster, H. and Cassileth, P.A.: Fludarabine therapy of non-Hodgkin’s Lymphoma. SeminarsOncol. 17:63-65,1990. 
18. Cassileth, P.A., Cheuvart, B., Spiers, A.S.D., Harrington, D.P., Cummings, F.J., Neiman, R.S., Bennett, J.M. and 
O’Connell, M.J.: Pentostatin induces durable remissions in hairy cell leukemia. J. Clin. Oncol. ,9:243-246, 1991. 
19. Stadtmauer, E.A., Cassileth, P.A., Edelstein, M., Abrahm, J., Schreiber, A.D., Nowell, P.C., and Cines, D.B.:Danazol 
treatment of myelodysplastic syndromes. Brit. J. Haemat., 77:502-508, 1991. 
20. Bennett, J.M., Andersen, J. and Cassileth, P.A.: Long-term survival in acute myeloid leukemia: The Eastern 
Cooperative Oncology Group (ECOG) experience. Leukemia Res. 15:223-227, 1991. 
21. Cassileth, P.A., Andersen, J., Lazarus, H.M., Kaizer, H., Bloom, E., Elfenbein, G.J., Santos, G.W., Bennett, J.M., 
Colvin, O.H. and Oken, M.M.: Autologous bone marrow transplantation in acute myeloid leukemia in first remission: 
an Eastern Cooperative Oncology Group pilot study. In Autologous Bone Marrow Transplantation: Proceedings of 
the Fifth International Symposium, University of Nebraska Medical Center, 1991, p. 37-42. 
22. Paietta, E., VanNess, B., Bennett, J.M., Pellone, C., Billadeau, D., Cassileth, P.A. and Wiemik, P.H.: Unexpected 
immunoglobulin light chain gene rearrangements in myeloid antigen acute lymphoid leukemias. Leukemia Res. 15: 
149-155,1991. 
23. Kramer, Z.B., Boros, L., Wiemik, P.H., Andersen, J., Bennett, J.M., Cassileth, P., and Oken, M.: 13 cis- retinoic acid 
in the treatment of elderly patients with acute myeloid leukemia. A phase II ECOG pilot study. Cancer 67: 1484-6, 
1991. 
24. Hochster, H.S., Kyungmann, K., Green, M.D., Mann, R.B., Neiman, R.S., Oken, M.M., Cassileth, P.A., Harris, J.E., 
Tormey, D.C. and O’Connell, J.J.: Activity of fludarabine in previously treated non-Hodgkin’s low grade lymphoma. 
Results of an Eastern Cooperative Oncology Group study. J. Clin. Oncol. 10:28-32. 
25. Nowell, P.C., Kant, J.A., Finan, J.B., Cassileth, P.A., and Hanson, C.A.: Marrow fibrosis associated with a Philadel 
phia chromosome. Cancer Genet Cytogen, 59:89-92, 1992. 
26. Cassileth, P.A., Lynch, E., Hines, J.D., Oken, M. M., Maza, J.J., Bennett, J.M., McGlave, P.B., Edelstein, M., 
Harrington, D.P., and O'Connell, M.J.: Varying intensity of post-remission therapy in acute myeloid leukemia. 
Blood, 79:1924-30, 1992. 
27. Paietta, E., VanNess, B„ Lebeau, M.M., Bennett, J.I. Cassileth, P.A., and Wiemik, P.H.: Translocation (2;9) 
(pl2:p23) in a case of acute leukemia with t(4: 11) (q21:23): lack of rearrangement of the kappa and interferon gene 
loci. Cancer Genet. Cytogenet. 60:82-85,1992. 
28. Vogler, W.R., Harrington, D.P., Winton, E.,F., Lazarus, H.M., Bennett, J.M., and Cassileth, P.A.: A phase II trial of 
carboplatin in relapsed and refactory leukemia. Leukemia 6:1072-75, 1992. 
29. Paietta, E„ VanNess, B„ Bennett, J., Racevskis, J., Gucalp, R„ Cassileth, P.A., and Wiemik, P.: Lymphoid lineage- 
associated features in acute myeloid leukemia: phenotypic and genotypic correlations. Brit. J. Haemat. 82:324-331, 
1992. 
30. Cassileth, P.A., Andersen, J., Lazarus, H.M., Colvin, O.H., Bennett, J.M., Stadtmauer, E.A., Kaizer, H., Weiner, 
R.S., Edelstein, M., Oken, M.M.: Autologous bone marrow transplant in acute myeloid leukemia in first remission. 
J. Clin. Oncol. 11:314-319, 1993. 
[270] 
Recombinant DNA Research, Volume 18 
